AskVantage

Amgen Inc.

Amgen Inc. is number 221 in the 311 Titans Index of the world's largest companies, with reported revenue of about $36.8bn in 2025. It is headquartered in Thousand Oaks, United States. 311 Future Exposure: medium (43/100), driven by technology change in healthcare (76/100), led by 5G, Artificial Narrow Intelligence, Biometric Sensors.

Part of the 311 Titans Index (311institute.com). Last updated .

221Rank
$36.8bnRevenue
2025Year
HealthSector
Thousand Oaks, United StatesHeadquarters
Nasdaq: AMGNListing
Medium (43/100)311 Future Exposure
See it on the interactive mapBook a Briefing

R&D labs

Amgen Inc. runs 1 research and innovation lab in the Global R&D Labs Directory: Amgen R&D.

311 Future Exposure: Medium

Score 43 out of 100: technology 76/100 and trends 10/100. What drives it:

Technology exposure uses the 311 Starburst: how strongly each emerging technology affects this industry, weighted by how soon it reaches widespread use. Trend exposure covers tariffs and export controls, international sanctions. Evidence on company-specific trends is being added. Explore the Starburst.

Other Titans in United States

Related

Questions and answers

How big is Amgen Inc.?

Amgen Inc. reported revenue of about $36.8bn in 2025, ranking number 221 in the 311 Titans Index.

Where is Amgen Inc. headquartered?

Amgen Inc. is headquartered in Thousand Oaks, United States.

Does Amgen Inc. run R&D labs?

Yes. The Global R&D Labs Directory lists 1 of its labs.

Source: SEC filing.

© 311 Institute 2026. Facts from official filings, Wikidata (CC0) and the sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.